Hatchtech Pty Ltd is an innovative biotechnology company developing novel solutions for everyday health problems based in Melbourne, Australia. Its lead development product, Xeglyze™, is a single dose, single treatment, topical prescription product for the control of head lice. Xeglyze was approved by the FDA in July 2020 and is currently available for partnering.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.